A Retrospective Case Series of Synovial Sarcoma of the Upper Extremity

J. Post, M. Houdek, A. L. Folpe, Sanjeev Kakar, B. K. Wilke

Research output: Contribution to journalArticle

Abstract

Purpose. Previous studies have grouped the treatment of axial and appendicular synovial sarcomas. The purpose of this study was to assess the prognostic variables of upper extremity synovial sarcomas (UESS) and compare the outcomes of those who underwent a nononcologic or inadvertent excision prior to definitive resection to those who underwent an initial oncologic resection. Methods. We reviewed the records of 23 UESS treated with definitive surgery at our institution between 1990 and 2014. There were 13 women and 10 men with a median age of 30 years (6-60) and median follow-up of 63 months (15-248). Prognostic variables, recurrence-free survival (RFS), and overall survival (OS) were then assessed. Results. Fifteen patients (65%) had a prior unplanned excision. Five patients required an amputation to obtain local control of disease. There were 3 observed local recurrences and 2 distant metastases at a median of 45 months from presentation. We found no difference in need for amputation, RFS, or OS between those who had undergone a planned excision and those who had an unplanned excision. Conclusion. While we were unable to find a significant difference in outcomes or amputation rates between those who underwent reexcision of a previously unplanned excision and those who underwent an initial planned resection, the high rate of unplanned excision is troubling and should remind practitioners to consider sarcoma in the differential of all upper extremity masses.

Original languageEnglish (US)
Article number8704936
JournalSarcoma
Volume2019
DOIs
StatePublished - Jan 1 2019

Fingerprint

Synovial Sarcoma
Upper Extremity
Amputation
Survival
Recurrence
Sarcoma
Neoplasm Metastasis

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

A Retrospective Case Series of Synovial Sarcoma of the Upper Extremity. / Post, J.; Houdek, M.; Folpe, A. L.; Kakar, Sanjeev; Wilke, B. K.

In: Sarcoma, Vol. 2019, 8704936, 01.01.2019.

Research output: Contribution to journalArticle

Post, J. ; Houdek, M. ; Folpe, A. L. ; Kakar, Sanjeev ; Wilke, B. K. / A Retrospective Case Series of Synovial Sarcoma of the Upper Extremity. In: Sarcoma. 2019 ; Vol. 2019.
@article{a0262af014024b25a55179de75cbca22,
title = "A Retrospective Case Series of Synovial Sarcoma of the Upper Extremity",
abstract = "Purpose. Previous studies have grouped the treatment of axial and appendicular synovial sarcomas. The purpose of this study was to assess the prognostic variables of upper extremity synovial sarcomas (UESS) and compare the outcomes of those who underwent a nononcologic or inadvertent excision prior to definitive resection to those who underwent an initial oncologic resection. Methods. We reviewed the records of 23 UESS treated with definitive surgery at our institution between 1990 and 2014. There were 13 women and 10 men with a median age of 30 years (6-60) and median follow-up of 63 months (15-248). Prognostic variables, recurrence-free survival (RFS), and overall survival (OS) were then assessed. Results. Fifteen patients (65{\%}) had a prior unplanned excision. Five patients required an amputation to obtain local control of disease. There were 3 observed local recurrences and 2 distant metastases at a median of 45 months from presentation. We found no difference in need for amputation, RFS, or OS between those who had undergone a planned excision and those who had an unplanned excision. Conclusion. While we were unable to find a significant difference in outcomes or amputation rates between those who underwent reexcision of a previously unplanned excision and those who underwent an initial planned resection, the high rate of unplanned excision is troubling and should remind practitioners to consider sarcoma in the differential of all upper extremity masses.",
author = "J. Post and M. Houdek and Folpe, {A. L.} and Sanjeev Kakar and Wilke, {B. K.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1155/2019/8704936",
language = "English (US)",
volume = "2019",
journal = "Sarcoma",
issn = "1357-714X",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - A Retrospective Case Series of Synovial Sarcoma of the Upper Extremity

AU - Post, J.

AU - Houdek, M.

AU - Folpe, A. L.

AU - Kakar, Sanjeev

AU - Wilke, B. K.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purpose. Previous studies have grouped the treatment of axial and appendicular synovial sarcomas. The purpose of this study was to assess the prognostic variables of upper extremity synovial sarcomas (UESS) and compare the outcomes of those who underwent a nononcologic or inadvertent excision prior to definitive resection to those who underwent an initial oncologic resection. Methods. We reviewed the records of 23 UESS treated with definitive surgery at our institution between 1990 and 2014. There were 13 women and 10 men with a median age of 30 years (6-60) and median follow-up of 63 months (15-248). Prognostic variables, recurrence-free survival (RFS), and overall survival (OS) were then assessed. Results. Fifteen patients (65%) had a prior unplanned excision. Five patients required an amputation to obtain local control of disease. There were 3 observed local recurrences and 2 distant metastases at a median of 45 months from presentation. We found no difference in need for amputation, RFS, or OS between those who had undergone a planned excision and those who had an unplanned excision. Conclusion. While we were unable to find a significant difference in outcomes or amputation rates between those who underwent reexcision of a previously unplanned excision and those who underwent an initial planned resection, the high rate of unplanned excision is troubling and should remind practitioners to consider sarcoma in the differential of all upper extremity masses.

AB - Purpose. Previous studies have grouped the treatment of axial and appendicular synovial sarcomas. The purpose of this study was to assess the prognostic variables of upper extremity synovial sarcomas (UESS) and compare the outcomes of those who underwent a nononcologic or inadvertent excision prior to definitive resection to those who underwent an initial oncologic resection. Methods. We reviewed the records of 23 UESS treated with definitive surgery at our institution between 1990 and 2014. There were 13 women and 10 men with a median age of 30 years (6-60) and median follow-up of 63 months (15-248). Prognostic variables, recurrence-free survival (RFS), and overall survival (OS) were then assessed. Results. Fifteen patients (65%) had a prior unplanned excision. Five patients required an amputation to obtain local control of disease. There were 3 observed local recurrences and 2 distant metastases at a median of 45 months from presentation. We found no difference in need for amputation, RFS, or OS between those who had undergone a planned excision and those who had an unplanned excision. Conclusion. While we were unable to find a significant difference in outcomes or amputation rates between those who underwent reexcision of a previously unplanned excision and those who underwent an initial planned resection, the high rate of unplanned excision is troubling and should remind practitioners to consider sarcoma in the differential of all upper extremity masses.

UR - http://www.scopus.com/inward/record.url?scp=85071248120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071248120&partnerID=8YFLogxK

U2 - 10.1155/2019/8704936

DO - 10.1155/2019/8704936

M3 - Article

AN - SCOPUS:85071248120

VL - 2019

JO - Sarcoma

JF - Sarcoma

SN - 1357-714X

M1 - 8704936

ER -